Annals of oncology
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
Oxford Journals Medicine Annals of Oncology
Journal of the European Society for Medical Oncology. Publishes articles across a multi-disciplinary spectrum.
IngentaConnect Publication: Annals of Oncology
Ann Oncol — Archive of Issues by Date
Oxford Journals · Medicine · Annals of Oncology; Issue Archive. spacer gif. Archive of All Online Issues: 1 Jan 1990 - 1 Apr 2008 …
Annals of Oncology logo Springer logo. Publisher: Springer. 82 issues are available electronically. Key:. Free Content - Free Content. New Content …
annals of oncology
www.springerlink.com/openurl.asp?genre=journal&issn=0923-7534 - Similar pages
Annals of Oncology - Oncology Journals, Books & Online Media …
pittsburgh, april 21 - mylan inc. (nyse: myl) today announced that mylan pharmaceuticals inc. has received final approval from the u.s. food and remedy administration (fda) appropriate for its abbreviated new drug application (anda) for felodipine extended-release tablets usp, 2.5 mg, 5 mg and 10 mg. felodipine extended-unshackle tablets usp are the generic version of astrazeneca pharmaceutical’s plendil(r) extended-release tablets, which had u.s. …
IngentaConnect Publication: Annals of Oncology
Annals of Oncology is a multidisciplinary journal that publishes articles addressing medical oncology, surgery, radiotherapy, paediatric oncology, …
Related posts: Reign on me, Do the right thing, Jane krakowski, Hollowman, Rousso